Institution
Indiana Hemophilia and Thrombosis Center
Also known as: IHTC
- 12running trials
- 4closed trials
- 587publications (OpenAlex)
Running trials
Recruiting
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
Recruiting
Recruiting
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Recruiting
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Haemophilia5 recruiting
- Sickle cell disease3 recruiting
- Iron deficiency anaemia1 recruiting
- Thalassaemia1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Registry name variants (7)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana 46260
5 trials
Indiana Hemophilia and Thrombosis Center
Indianapolis, Indiana 46260
4 trials
Indiana Hemophilia and Thrombosis Center, Inc
Indianapolis, Indiana 46260
2 trials
Indiana Hemophilia & Thrombosis Center, Inc.
Indianapolis, Indiana 46260
2 trials
Innovative Hematology - Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana 46260
2 trials
NCT07935356A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
Contact: Clinical Trials
NCT07187973A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Contact: Nehal Sheth
Indiana Hemophilia and Thrombosis Center- Site Number : 8400006
Indianapolis, Indiana 46260
1 trial
Indiana Hemophilia and Thrombosis Center- Site Number : 8400013
Indianapolis, Indiana 46260-1920
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Haemophilia15 works · 12 trials
Institution data: ROR 05j1fg548 (CC0-1.0)Updated 15 Nov 2026